Media Centre
Latest press releases
-
AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases
-
Efzimfotase alfa showed numerical improvement in Six-Minute Walk Test achieving mean difference of 17.05 metres vs placebo in treatment-naïve adolescents and adults with hypophosphatasia at week 25 in HICKORY Phase III trial
-
Alexion to showcase Phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting
-
AstraZeneca opens new global strategic R&D centre in Kendall Square, Cambridge, Massachusetts
-
AstraZeneca completes equity investment in Summit Therapeutics
-
AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
